The origins of mesenchymal stromal cell heterogeneity
- PMID: 21437576
- DOI: 10.1007/s12015-011-9229-7
The origins of mesenchymal stromal cell heterogeneity
Abstract
Cultured mesenchymal stromal cell (MSC) populations are best characterized by the capacity of some cells within this population to differentiate into mesodermal derivatives such as osteoblasts, chondrocytes and adipocytes. However, this progenitor property is not shared by all cells within the MSC population. Furthermore, MSCs exhibit variability in their phenotypes, including proliferation capacity, expression of cell surface markers and ability to secrete cytokines. These facts raise three major questions: (1) Does the in vitro observed variability reflect the existence of MSC subsets in vivo? (2) What is the molecular basis of the in vitro observed heterogeneity? and (3) What is the biological significance of this variability? This review considers the possibility that the variable nature of MSC populations contributes to the capacity of adult mammalian tissues to adapt to varying microenvironmental demands.
Similar articles
-
Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential.Stem Cell Rev Rep. 2013 Feb;9(1):32-43. doi: 10.1007/s12015-012-9365-8. Stem Cell Rev Rep. 2013. PMID: 22529014 Free PMC article.
-
Characterization of mesenchymal stem cells isolated from mouse fetal bone marrow.Stem Cells. 2006 Mar;24(3):482-93. doi: 10.1634/stemcells.2005-0219. Epub 2005 Sep 22. Stem Cells. 2006. PMID: 16179426
-
Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.Stem Cells. 2008 Nov;26(11):2884-92. doi: 10.1634/stemcells.2008-0329. Epub 2008 Aug 7. Stem Cells. 2008. PMID: 18687994
-
The stem state: mesenchymal plasticity as a paradigm.Curr Stem Cell Res Ther. 2006 Jan;1(1):95-102. doi: 10.2174/157488806775269133. Curr Stem Cell Res Ther. 2006. PMID: 18220858 Review.
-
From bone to brain: human skeletal stem cell therapy for stroke.Cent Nerv Syst Agents Med Chem. 2011 Jun 1;11(2):157-63. doi: 10.2174/187152411796011376. Cent Nerv Syst Agents Med Chem. 2011. PMID: 21521166 Review.
Cited by
-
Exploiting bone niches: progression of disseminated tumor cells to metastasis.J Clin Invest. 2021 Mar 15;131(6):e143764. doi: 10.1172/JCI143764. J Clin Invest. 2021. PMID: 33720051 Free PMC article. Review.
-
Electrospun nanofiber mesh with connective tissue growth factor and mesenchymal stem cells for pelvic floor repair: Long-term study.J Biomed Mater Res B Appl Biomater. 2023 Feb;111(2):392-401. doi: 10.1002/jbm.b.35158. Epub 2022 Sep 8. J Biomed Mater Res B Appl Biomater. 2023. PMID: 36075108 Free PMC article.
-
A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus.Stem Cells Dev. 2012 Sep 20;21(14):2689-702. doi: 10.1089/scd.2011.0643. Epub 2012 May 14. Stem Cells Dev. 2012. PMID: 22462538 Free PMC article.
-
Semaphorin 3A regulates alveolar bone remodeling on orthodontic tooth movement.Sci Rep. 2022 Jun 2;12(1):9243. doi: 10.1038/s41598-022-13217-x. Sci Rep. 2022. PMID: 35654941 Free PMC article.
-
Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs).Front Cell Dev Biol. 2014 Sep 12;2:50. doi: 10.3389/fcell.2014.00050. eCollection 2014. Front Cell Dev Biol. 2014. PMID: 25364757 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources